3386.T
COSMO BIO COMPANY,LIMITED
スタンダード · 卸売業 · 商社・卸売 · JP
JPY 1,251.00
−0.32%Year over year
Reported trailing growth
- Revenue
- +7.3%
- EBITDA
- —
- EBIT
- +7.9%
- EPS
- +31.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -0.6%
- EBITDA
- —
- EPS
- +28.2%
Three-year CAGR
- Revenue
- +4.1%
- EBITDA
- -18.9%
- EBIT
- -25.1%
- Net income
- -13.3%
- EPS
- -12.7%
- Free cash flow
- +16.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026